SharonSBurkeMD

PubMed

• A novel fluorogenic substrate for the measurement of endothelial lipase activity.
  Darrow, A.L., Olson, M.W., Xin, H., Burke, S.L., Smith, C., Schalk-Hihi, C., Williams, R., Bayoumy, S.S., Deckman, I.C., Todd, M.J., Damiano, B.P., Connelly, M.A.> ;J Lipid Res. 2011 Feb
• KChIPs and Kv4 alpha subunits as integral components of A-type potassium channels in mammalian brain.
  Rhodes, K.J., Carroll, K.I., Sung, M.A., Doliveira, L.C., Monaghan, M.M., Burke, S.L., Strassle, B.W., Buchwalder, L., Menegola, M., Cao, J., An, W.F., Trimmer, J.S.> ;J Neurosci. 2004 Sep 8
• 16 citations
  Comparison of the effects of two viscoelastic agents, Healon and Viscoat, on postoperative intraocular pressure after penetrating keratoplasty.
  Sharon Burke, Joel Sugar, Marilyn D Farber> ;Ophthalmic Surgery. 1990 Dec 1
• Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.
  Zhang, Y. M., Fan, X., Xiang, B., Chakravarty, D., Scannevin, R., Burke, S., Karnachi, P., Rhodes, K., Jackson, P.> ;Bioorg Med Chem Lett. 2006 Jun 15
• beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.
  Yang, S. M., Scannevin, R. H., Wang, B., Burke, S. L., Wilson, L. J., Karnachi, P., Rhodes, K. J., Lagu, B., Murray, W. V.> ;Bioorg Med Chem Lett. 2008 Feb 1
• beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.
  Yang, S. M., Scannevin, R. H., Wang, B., Burke, S. L., Huang, Z., Karnachi, P., Wilson, L. J., Rhodes, K. J., Lagu, B., Murray, W. V.> ;Bioorg Med Chem Lett. 2008 Feb 1
• 1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.
  Zhang, Y. M., Fan, X., Chakaravarty, D., Xiang, B., Scannevin, R. H., Huang, Z., Ma, J., Burke, S. L., Karnachi, P., Rhodes, K. J., Jackson, P. F.> ;Bioorg Med Chem Lett. 2008 Jan 1
• Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).
  Zhang, Y. M., Fan, X., Yang, S. M., Scannevin, R. H., Burke, S. L., Rhodes, K. J., Jackson, P. F.> ;Bioorg Med Chem Lett. 2008 Jan 1
• Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.
  Wilson, L. J., Wang, B., Yang, S. M., Scannevin, R. H., Burke, S. L., Karnachi, P., Rhodes, K. J., Murray, W. V.> ;Bioorg Med Chem Lett. 2011 Nov 1
• Join now to see all